More Efficient Tools to Realize Information for Consumers Act
Latest action · Sep 24, 2019 Placed on the Union Calendar, Calendar No. 170.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 12, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
More Efficient Tools to Realize Information for Consumers Act or the METRIC Act
This bill requires prescription drug manufacturers to report, and the Department of Health and Human Services (HHS) to publish, specified information related to prescription drug pricing and the pharmaceutical supply chain. Specifically, HHS must publish reports submitted by drug manufacturers that include the percentage of any wholesale drug price increase that is greater than 10% in one calendar year (or 25% over three consecutive years), an explanation for the price increase, and other data. HHS must enter agreements with other agencies, research organizations, and public and private health insurers to share data submitted to HHS by drug manufacturers about the identity and quantity of drug sample requests by health practitioners.
HHS also must publish online aggregate data reported by pharmacy benefits managers (PBMs), including the percentage of prescriptions provided by mail-order, rate that generic versions of drugs are dispensed, and aggregate discounts, rebates, or price concessions negotiated.
The bill requires the Federal Trade Commission to report about potentially anticompetitive practices by PBMs such as steering patients to certain pharmacies or designing price formulas that increase the market share of higher priced drugs, among other information. The report also must include recommendations to increase transparency and deter anticompetitive behavior.
The bill further requires Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that provides prescribers with patient-specific formulary and benefit information. Additionally, the bill expands certain price reporting requirements for prescription drug payments under Medicare.
Cosponsors 8
Members who signed on, in the order they did. Signatures ran from Apr 12, 2019 to Sep 19, 2019; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-FL | Francis Rooney | Original | Apr 12, 2019 |
| D-MD | John P. Sarbanes | Jul 12, 2019 | |
| D-IL | Lauren Underwood | Jul 12, 2019 | |
| D-TX | Lloyd Doggett | Jul 12, 2019 | |
| R-VA | H. Morgan Griffith | Jul 18, 2019 | |
| D-NY | Thomas R. Suozzi | Aug 20, 2019 | |
| R-GA | Earl L. "Buddy" Carter | Sep 19, 2019 | |
| D-WI | Mark Pocan | Sep 19, 2019 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 12, 2019Markup Jul 17, 2019Reported Sep 24, 2019 |
| Health Subcommittee | Referred Apr 15, 2019Hearings May 21, 2019Markup Jul 11, 2019Reported Jul 11, 2019 |
Actions 10
Everything that happened, newest first.
- Sep 24, 2019Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215.
- Sep 24, 2019Placed on the Union Calendar, Calendar No. 170.
- Jul 17, 2019Committee Consideration and Mark-up Session Held.
- Jul 17, 2019Ordered to be Reported (Amended) by Voice Vote.
- Jul 11, 2019Subcommittee Consideration and Mark-up Session Held.
- Jul 11, 2019Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
- May 21, 2019Subcommittee Hearings Held.
- Apr 15, 2019Referred to the Subcommittee on Health.
- Apr 12, 2019Introduced in House
- Apr 12, 2019Referred to the House Committee on Energy and Commerce.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H10118 | Earl L. "Buddy" Carter R-GA | Dec 11, 2019 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Sep 18, 2019H.R. 2296, METRIC ActAs ordered reported by the House Committee on Energy and Commerce on July 17, 2019
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 64, April 12, 2019, page H3265.
Printed hearings 4
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 116-55 | THE PATIENT PERSPECTIVE: THE DEVASTATING IMPACTS OF SKYROCKETING DRUG PRICES ON AMERICAN FAMILIES45 pages | Oversight and Government Reform Committee | Jul 26, 2019 |
| Serial No. 116-57 | MEMBER DAY HEARING208 pages | Energy and Commerce Committee | Jul 25, 2019 |
| Serial No. 116-37 | IMPROVING DRUG PRICING TRANSPARENCY AND LOWERING PRICES FOR AMERICAN CONSUMERS193 pages | Energy and Commerce Committee | May 21, 2019 |
| Serial No. 116-32 | LOWERING PRESCRIPTION DRUG PRICES: DECON-STRUCTING THE DRUG SUPPLY CHAIN313 pages | Energy and Commerce Committee | May 9, 2019 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46741 | Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress | Report | Mar 31, 2021 |
Related bills 14
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 3 | Elijah E. Cummings Lower Drug Costs Now Act | Related bill | Sep 8, 2020 |
| HR 19 | Lower Costs, More Cures Act of 2019 | Related bill | Dec 19, 2019 |
| S 1227 | Prescription Pricing for the People Act of 2019 | Related bill | Jun 28, 2019 |
| S 1391 | Fair Accountability and Innovative Research Drug Pricing Act of 2019 | Related bill | May 9, 2019 |
| S 1895 | Lower Health Care Costs Act | Related bill | Jul 8, 2019 |
Titles 4
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To require reporting regarding certain drug price increases, and for other purposes.
- Short Title(s) as Introduced
- FAIR Drug Pricing Act of 2019
- Fair Accountability and Innovative Research Drug Pricing Act of 2019
- Short Title(s) as Reported to House
- More Efficient Tools to Realize Information for Consumers Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 2
Each version as it was printed, newest first.
- Sep 24, 2019Reported in House
- Apr 12, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.